Induction FLOT With CROSS CRT for Esophageal Cancer
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates a novel regimen of induction chemotherapy using a combination of
docetaxel, oxaliplatin, and leucovorin, with short term infusional 5-FU (FLOT), given prior
to chemoradiotherapy with concurrent carboplatin and paclitaxel, as neoadjuvant therapy prior
to definitive surgical resection for patients with adenocarcinoma of the esophagus or
gastroesophageal junction